LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide. The company is headquartered in Burlington, Massachusetts.
| Revenue (TTM) | $249.60M |
| Gross Profit (TTM) | $175.84M |
| EBITDA | $73.53M |
| Operating Margin | 21.80% |
| Return on Equity | 15.80% |
| Return on Assets | 6.76% |
| Revenue/Share (TTM) | $11.03 |
| Book Value | $17.28 |
| Price-to-Book | 6.28 |
| Price-to-Sales (TTM) | 10.07 |
| EV/Revenue | 9.21 |
| EV/EBITDA | 25.31 |
| Quarterly Earnings Growth (YoY) | 41.40% |
| Quarterly Revenue Growth (YoY) | 15.70% |
| Shares Outstanding | $22.78M |
| Float | $21.15M |
| % Insiders | 7.93% |
| % Institutions | 96.29% |